3月11日,Fennec Pharmaceuticals Inc.(FENC.US)公布财报,公告显示公司2024财年净利润为-70000.00美元,同比增加99.56%;其中营业收入为47.54百万美元,同比增加123.72%,每股基本收益为0.00美元。从资产负债表来看,Fennec Pharmaceuticals Inc.(FENC.US)总负债50.45百万美元,其中短期债务...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.